miR-708 Study Reveals Triple Negative Breast Cancer's Metastatic Path

"In the study, researchers set out to identify a miRNA that impacts metastasis without affecting primary tumor growth, as well as address its underlying molecular mechanisms and therapeutic potential against metastatic breast cancer. They discovered that a miRNA known as miR-708 is inhibited in metastatic triple negative breast cancer. They found that miR-708 acts as a metastatic tumor inhibitor, and when its function is restored, the tumors do not spread or form lethal macrometastases..."

http://weill.cornell.edu/news/releases/wcmc/wcmc_2013/01_14_13.shtml
(Click link for full story)